Bartonella henselae Endocarditis: An Usual Presentation of an Unusual Disease

Authors

• Aasem Abu Shtaya Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
• Shoshan Perek Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
• Adi Kibari Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
• Shai Cohen Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel

Aasemab@hotmail.com

Keywords

Abstract

Bartonella species are an emerging cause of culture-negative endocarditis with more cases being diagnosed now than 25 years ago when Bartonella quintana endocarditis was first described in a patient infected with human immunodeficiency virus (HIV). Despite the disease being increasingly reported, the exact epidemiological features are not clear, with prevalence rates ranging between 2% and 10% of all cases of culture-negative endocarditis. Moreover, the mortality rate is still high, presumably because of the subacute nature and relative rareness of the disease. Bartonella endocarditis occurs more often in men, and previous valvular surgery is a major risk factor. There is insufficient data to guide definitive treatment due to the paucity of literature. A previous study demonstrated that effective antibiotic therapy for Bartonella endocarditis should include an aminoglycoside prescribed for a minimum of 2 weeks. However, the treatment strategy is a matter of expert opinion